1. Sealutomicins, new enediyne antibiotics from the deep-sea actinomycete Nonomuraea sp. MM565M-173N2
- Author
-
Maya Umekita, Yoshimasa Ishizaki, Chiaki Kato, Masato Suzuki, Rie Arisaka, Ryuichi Sawa, Masayuki Igarashi, Chigusa Hayashi, and Masaki Hatano
- Subjects
0301 basic medicine ,Geologic Sediments ,medicine.drug_class ,030106 microbiology ,Antibiotics ,01 natural sciences ,Microbiology ,03 medical and health sciences ,Antibiotic resistance ,Drug Discovery ,Enediyne ,medicine ,Pharmacology ,Molecular Structure ,biology ,Strain (chemistry) ,010405 organic chemistry ,Chemistry ,biology.organism_classification ,Enterobacteriaceae ,Anti-Bacterial Agents ,0104 chemical sciences ,Actinobacteria ,Fermentation ,Antibacterial activity ,Bacteria - Abstract
A Nonomuraea sp. strain MM565M-173N2 was isolated from deep-sea sediment off the Sanriku coast, and new antibiotics were evaluated against carbapenem-resistant Enterobacteriaceae (CRE), which is a problematic group of bacteria because of their antimicrobial resistance. From 220 l of fermented broth from strain MM565M-173N2, we isolated four new antibiotics by gel filtration and HPLC, designated as sealutomicins A (1.8 mg), B (1.5 mg), C (0.8 mg), and D (0.8 mg). Their structures were determined from MS, NMR, and CD spectra. Sealutomicin A was found to be a new enediyne antibiotic, while sealutomicins B-D were aromatized products from sealutomicin A. Sealutomicin A showed strong antibacterial activity (MIC 0.05-0.2 μg ml-1) against CRE.
- Published
- 2021
- Full Text
- View/download PDF